SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

$ZSTK

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

COPIED JUL 21

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

ALXNSell

Alexion Pharmaceuticals, Inc.

Daniel Bazarko · SVP, Controller, CAO

$3.8M−44.0%Dec 21
ALXNSell

Alexion Pharmaceuticals, Inc.

Tanisha Carino · EVP, CCAO

$187K−9.0%Dec 4
ALXNSell

Alexion Pharmaceuticals, Inc.

Indrani Lall Franchini · EVP and Chief Compliance Officer

$786K−20.0%Jun 9
ALXNSell

Alexion Pharmaceuticals, Inc.

Indrani Lall Franchini · EVP and Chief Compliance Officer

$598K−13.0%Jul 2
ALXNSell

Alexion Pharmaceuticals, Inc.

Aradhana Sarin · Chief Strategy, Business Off

$76K−2.0%Jun 24
ALXNSell

Alexion Pharmaceuticals, Inc.

Baker Bros. Advisors LP · Director

$37.1M−4.0%May 30
ALXNSell

Alexion Pharmaceuticals, Inc.

Daniel Bazarko · SVP, Controller, CAO

$252K−28.0%Feb 19
ALXNSell

Alexion Pharmaceuticals, Inc.

Ludwig Hantson · CEO

$311K−2.0%Jan 3
ALXNSell

Alexion Pharmaceuticals, Inc.

Indrani Lall Franchini · EVP and Chief Compliance Officer

$308K−8.0%Nov 30
ALXNSell

Alexion Pharmaceuticals, Inc.

Paul J Clancy · EVP and CFO

$687K−5.0%Jul 12
ALXNSell

Alexion Pharmaceuticals Inc

Brian Goff · EVP and Chief Commercial Officer

$195K−4.0%Jun 12
ALXNSell

Alexion Pharmaceuticals Inc

Indrani Lall Franchini · EVP and Chief Compliance Officer

$174K−4.0%Jun 12
ALXNSell

Alexion Pharmaceuticals Inc

Anne-Marie Law · EVP and CHRO

$221K−6.0%Jun 12
ALXNSell

Alexion Pharmaceuticals Inc

John J Orloff · EVP, Research, Development

$251K−6.0%Jun 12
ALXNSell

Alexion Pharmaceuticals Inc

Julie O'Neill · EVP. Global Operations

$195K−4.0%Mar 1
ALXNSell

Alexion Pharmaceuticals Inc

Heidi L Wagner · SVP, Global Government Affairs

$83K−1.0%Mar 1
ALXNSell

Alexion Pharmaceuticals Inc

Brian Goff · EVP and Chief Commercial Officer

$192K−5.0%Feb 8
ALXNSell

Alexion Pharmaceuticals Inc

Julie O'Neill · EVP. Global Operations

$557K−10.0%Feb 8
ALXNSell

Alexion Pharmaceuticals Inc

Ludwig Hantson · CEO

$1.5M−10.0%Feb 8
ALXNSell

Alexion Pharmaceuticals Inc

Heidi L Wagner · SVP, Global Government Affairs

$206K−3.0%Feb 8
ALXNSell

Alexion Pharmaceuticals Inc

Paul J Clancy · EVP and CFO

$707K−6.0%Feb 8
ALXNSell

Alexion Pharmaceuticals Inc

Indrani Lall Franchini · EVP and Chief Compliance Officer

$170K−6.0%Feb 8
ALXNSell

Alexion Pharmaceuticals Inc

John B Moriarty · EVP and General Counsel

$389K−4.0%Feb 8
ALXNSell

Alexion Pharmaceuticals Inc

Julie O'Neill · EVP. Global Operations

$248K−9.0%Feb 7
ALXNSell

Alexion Pharmaceuticals Inc

Heidi L Wagner · SVP, Global Government Affairs

$77K−2.0%Feb 7
ALXNSell

Alexion Pharmaceuticals Inc

John B Moriarty · EVP and General Counsel

$148K−2.0%Feb 7
ALXNSell

Alexion Pharmaceuticals Inc

Ludwig Hantson · CEO

$311K−7.0%Jan 4
ALXNSell

Alexion Pharmaceuticals Inc

Julie O'Neill · EVP. Global Operations

$636K−16.0%Sep 5
ALXNSell

Alexion Pharmaceuticals Inc

Ann M Veneman · Director

$122K−13.0%Sep 5
ALXNSell

Alexion Pharmaceuticals Inc

Julie O'Neill · EVP. Global Operations

$1.6M−29.0%Aug 30
ALXNSell

Alexion Pharmaceuticals Inc

Ann M Veneman · Director

$96K−10.0%Aug 2
ALXNSell

Alexion Pharmaceuticals Inc

Alvin S Parven · Director

$98K−10.0%Jun 16
ALXNSell

Alexion Pharmaceuticals Inc

Julie O'Neill · EVP. Global Operations

$87K−2.0%Mar 6
ALXNSell

Alexion Pharmaceuticals Inc

Carsten Thiel · EVP and Chief Commercial Officer

$496K−10.0%Mar 6
ALXNSell

Alexion Pharmaceuticals Inc

Julie O'Neill · EVP. Global Operations

$207K−4.0%Mar 1
ALXNSell

Alexion Pharmaceuticals Inc

Martin Mackay · EVP, Global Head of R, D

$244K−4.0%Mar 1
ALXNSell

Alexion Pharmaceuticals Inc

John B Moriarty · EVP and General Counsel

$238K−3.0%Mar 1
ALXNSell

Alexion Pharmaceuticals Inc

Edward Miller · SVP and Chief Compliance Officer

$78K−3.0%Mar 1
ALXNSell

Alexion Pharmaceuticals Inc

Clare Carmichael · EVP and CHRO

$287K−5.0%Mar 1
ALXNSell

Alexion Pharmaceuticals Inc

Heidi L Wagner · SVP, Global Government Affairs

$131K−3.0%Mar 1
ALXNSell

Alexion Pharmaceuticals Inc

Leonard Bell · Director

$525K−1.0%Mar 1
ALXNSell

Alexion Pharmaceuticals Inc

Martin Mackay · EVP, Global Head of R, D

$28K−1.0%Feb 10
ALXNSell

Alexion Pharmaceuticals Inc

Leonard Bell · Director

$31KFeb 10
ALXNSell

Alexion Pharmaceuticals Inc

Julie O'Neill · EVP. Global Operations

$351K−8.0%Feb 8
ALXNSell

Alexion Pharmaceuticals Inc

Martin Mackay · EVP, Global Head of R, D

$343K−6.0%Feb 8
ALXNSell

Alexion Pharmaceuticals Inc

Clare Carmichael · EVP and CHRO

$449K−9.0%Feb 8
ALXNSell

Alexion Pharmaceuticals Inc

John B Moriarty · EVP and General Counsel

$445K−7.0%Feb 8
ALXNSell

Alexion Pharmaceuticals Inc

Leonard Bell · Director

$1.1M−2.0%Feb 8
ALXNSell

Alexion Pharmaceuticals Inc

Edward Miller · SVP and Chief Compliance Officer

$131K−6.0%Feb 8
ALXNSell

Alexion Pharmaceuticals Inc

Heidi L Wagner · SVP, Global Government Affairs

$243K−6.0%Feb 8

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.